Exelixis | Crediti Commerciali



Trade Debtors Cambiamento Data
Acadia Pharmaceuticals USD 113.71M 9.02M 2025-03
Agios Pharmaceuticals USD 3.34M 765K 2025-03
Amgen USD 8.13B 1.35B 2025-03
AstraZeneca USD 14.82B 16M 2025-03
Bayer EUR 12.5B 1.33B 2024-12
BioMarin Pharmaceutical USD 739.18M 78.64M 2025-03
Bristol-Myers Squibb USD 14.59B 162M 2025-03
Cytokinetics USD 2.01M 14.64M 2025-03
Eisai JPY 235.64B 40.42B 2024-12
Eli Lilly USD 14B 727.8M 2025-03
Exelixis USD 265.44M 4.27M 2025-01
Genmab DKK 799M 5.89B 2025-03
Glaxosmithkline GBP 7.32B 542M 2024-12
Incyte USD 823.13M 30.02M 2025-03
Ionis Pharmaceuticals USD 39.71M 52.48M 2025-03
MacroGenics USD 4.31M 4.44M 2024-12
Merck USD 11.57B 452M 2025-03
Moderna USD 306M 286M 2025-03
Neurocrine Biosciences USD 479.1M 2M 2024-12
Novartis USD 9B 854M 2024-12
Pfizer USD 14.74B 32M 2025-03
Sanofi 10.63B 1.82B 2024-12
Takeda JPY 725.25B 9.81B 2025-03
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
Xencor USD 37.78M 23.06M 2025-03



Exelixis Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.